Skip to content

The value of nonoperative versus operative treatment of frail institutionalized elderly patient with a hip fracture in the shade of life (FRAIL-HIP); a multicenter observational study

The value of nonoperative versus operative treatment of frail institutionalized elderly patient with a hip fracture in the shade of life (FRAIL-HIP); a multicenter observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23054
Enrollment
160
Registered
2018-05-30
Start date
2018-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proximal femoral fracture

Interventions

Patients in the intervention group will be treated nonoperatively. The control group will receive operative management.

Sponsors

Noordwest Ziekenhuisgroep, Department of Surgery
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Frail institutionalized elderly person (i.e., 70 years or older, living in a nursing home pretrauma, who either are malnutritioned (cachexia of BMI<18.5 kg/m2), or had mobility issues (FAC 2 or less), or have an ASA class of 4 or 5) 2) Acute proximal femoral fracture, confirmed on X-ray or CT-scan 3) Informed consent by patient, or by proxy in patients with mental impairment

Exclusion criteria

Exclusion criteria: 1) Bilateral proximal femoral fractures 2) Periprosthetic fracture 3) Fracture diagnosed > 7 days after trauma 4) Patients with a known metastatic disease and a confirmed pathological fracture of the proximal femur 5) Insufficient comprehension of Dutch language to understand rehabilitation programs and other treatment information (this applies to the person signing consent, being either the patient or proxy) 6) Participation in another surgical intervention or drug study that might influence any of the outcome parameters

Design outcomes

Primary

MeasureTime frame
Quality of life, measured with the EuroQoL-5D

Secondary

MeasureTime frame
Quality of life measured with the QUALIDEM; pain and pain medication; satisfaction of patient (or proxy) and caregivers with the management approach; time to death; direct medical costs.

Contacts

Public ContactP. Joosse

Noordwest Ziekenhuisgroep, dept. of Surgery

p.joosse@nwz.nl072-5482422

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)